Literature DB >> 32601138

Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure.

Monique Oye1, Kimberly Sanders2, Maged Ghali3, Ahmad Alkhasawneh4.   

Abstract

We present a case of a 45-year-old man admitted to the hospital with new-onset ascites and bilateral subconjunctival haemorrhages. He was found to have elevated liver enzymes in a hepatocellular pattern and direct hyperbilirubinemia. A diagnostic paracentesis was consistent with portal hypertension (PH). Extensive workup for acute and chronic liver disease was unremarkable. In the absence of clinical evidence of cirrhosis to explain PH, a liver biopsy with hepatic venous pressure gradient was pursued, which revealed proteinaceous material and apple-green birefringence under polarised light consistent with amyloid deposits. Bone marrow biopsy revealed plasma cell neoplasm with proteinaceous deposits consistent with concomitant multiple myeloma with AL amyloidosis. He developed rapidly progressive liver failure and passed shortly after presentation despite treatment with chemotherapy. This case illustrates how primary hepatic amyloidosis can present with a physiology that mimics cirrhosis and can easily be missed. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  liver disease; malignant and benign haematology; malignant disease and immunosuppression; ophthalmology; portal hypertension

Mesh:

Year:  2020        PMID: 32601138      PMCID: PMC7326243          DOI: 10.1136/bcr-2020-234637

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Subacute liver failure secondary to amyloid light-chain amyloidosis.

Authors:  Theresa J Hydes; Richard J Aspinall
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

2.  Solid organ transplantation in AL amyloidosis.

Authors:  P T Sattianayagam; S D J Gibbs; J H Pinney; A D Wechalekar; H J Lachmann; C J Whelan; J A Gilbertson; P N Hawkins; J D Gillmore
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

Review 3.  Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?

Authors:  N J Bahlis; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2006-05-22       Impact factor: 5.483

Review 4.  Amyloidosis of the gastrointestinal tract and the liver: clinical context, diagnosis and management.

Authors:  Umer Syed; Rafael A Ching Companioni; Hassan Alkhawam; Aron Walfish
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-10       Impact factor: 2.566

Review 5.  Sinusoidal portal hypertension in hepatic amyloidosis.

Authors:  E Bion; R Brenard; E A Pariente; D Lebrec; C Degott; F Maitre; J P Benhamou
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

6.  Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.

Authors:  Miguel A Park; Paul S Mueller; Robert A Kyle; Dirk R Larson; Matthew F Plevak; Morie A Gertz
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

7.  Epidemiology of AL amyloidosis: a real-world study using US claims data.

Authors:  Tiffany P Quock; Tingjian Yan; Eunice Chang; Spencer Guthrie; Michael S Broder
Journal:  Blood Adv       Date:  2018-05-22

8.  A Case of Conjunctival Amyloidosis with Repeated Subconjunctival Hemorrhage.

Authors:  Takaaki Ando; Toshiyuki Oshitari; Mamiko Saito; Ayako Tawada; Takayuki Baba; Jiro Yotsukura; Shuichi Yamamoto
Journal:  Case Rep Ophthalmol Med       Date:  2017-02-23

9.  Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis.

Authors:  Siroj Dejhansathit; Attaya Suvannasankha
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

10.  Amyloidosis: an unusual cause of portal hypertension.

Authors:  Vilma Takayasu; Lorena Silva Laborda; Raquel Bernardelli; Henrique Trombini Pinesi; Marilia Polo Minguete E Silva; Viviane Chiavelli; Angélica Braz Simões; Aloisio Felipe-Silva
Journal:  Autops Case Rep       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.